Format

Send to

Choose Destination
Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Author information

1
Department of Dermatology, Fukushima Medical University, Fukushima, Japan.

Abstract

Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center